Personalized cancer treatments based on testing drugs quickly leads to faster treatment, better outcomes – The Conversation April 11, 2024
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients – Moderna Investor Relations February 22, 2023
Spotify 2022 Wrapped: How to Watch (and Rewatch) Your Personalized Recap December 1, 2022December 1, 2022
In a First, Scientists Used Personalized Brain Stimulation to Successfully Treat a Person’s Severe Depression October 4, 2021October 4, 2021